Healthcare | October 06, 2024
AIIMS, New organises conference on ‘Advancing Oral Health in India’
Poor oral health (periodontal disease) impacts nearly 51% of Indians
Poor oral health (periodontal disease) impacts nearly 51% of Indians
USFDA completes PAI of Lupin’s biotech facility in Pune
The company plans to advance Ropanicant into double-blind, placebo-controlled Phase-2b clinical study in MDD patients, anticipated to start in early 2025
The inspection conducted by EDQM at its Visakhapatnam facility
The observations are of procedural in nature and will be responded to within the stipulated time
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
India has taken the lead in recognising NAFLD as a major non-communicable disease
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit dramatically increase throughput for WGA by processing up to 1,500 cells per run
AMR poses a critical threat to global public health undermining decades of progress made in the field of modern medicine
Subscribe To Our Newsletter & Stay Updated
